Zuora (ZUO) 10-Q 31 Aug 22 2023 Q2 Quarterly report Financial data

Cover

Cover shares in Millions	6 Months Ended
	Jul. 31, 2022 shares
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-38451
Entity Registrant Name	Zuora, Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5530976
Entity Address, Address Line One	101 Redwood Shores Parkway
Entity Address, City or Town	Redwood City
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94065
City Area Code	888
Local Phone Number	976-9056
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	ZUO
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001423774
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	123.8
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	8.1

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 206,936	$ 113,507
Short-term investments	241,707	101,882
Accounts receivable, net of allowance for credit losses of $2,178 and $3,188 as of July 31, 2022 and January 31, 2022, respectively	67,693	82,263
Deferred commissions, current portion	15,833	15,080
Prepaid expenses and other current assets	18,851	15,603
Total current assets	551,020	328,335
Property and equipment, net	29,495	27,676
Operating lease right-of-use assets	28,573	32,643
Purchased intangibles, net	2,526	3,452
Deferred commissions, net of current portion	27,046	26,727
Goodwill	17,632	17,632
Other assets	4,639	4,787
Total assets	660,931	441,252
Current liabilities:
Accounts payable	7,652	6,785
Accrued expenses and other current liabilities	19,171	14,225
Accrued employee liabilities	29,197	32,425
Debt, current portion	0	1,660
Deferred revenue, current portion	148,162	152,740
Operating lease liabilities, current portion	10,327	11,462
Total current liabilities	214,509	219,297
Debt, net of current portion	206,426	0
Deferred revenue, net of current portion	945	771
Operating lease liabilities, net of current portion	41,533	45,633
Deferred tax liabilities	3,244	3,243
Other long-term liabilities	1,609	1,701
Total liabilities	468,266	270,645
Commitments and contingencies (Note 13)
Stockholders’ equity:
Additional paid-in capital	810,636	734,149
Accumulated other comprehensive loss	(1,459)	(108)
Accumulated deficit	(616,525)	(563,447)
Total stockholders’ equity	192,665	170,607
Total liabilities and stockholders’ equity	660,931	441,252
Class A common stock
Stockholders’ equity:
Common stock	12	12
Class B common stock
Stockholders’ equity:
Common stock	$ 1	$ 1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 2,178	$ 3,188

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Revenue:
Total revenue	$ 98,775	$ 86,487	$ 191,974	$ 166,816
Cost of revenue:
Total cost of revenue	38,649	35,992	74,884	68,713
Gross profit	60,126	50,495	117,090	98,103
Operating expenses:
Research and development	26,354	20,860	49,226	39,827
Sales and marketing	45,146	36,261	85,603	68,126
General and administrative	18,816	16,376	36,106	30,561
Total operating expenses	90,316	73,497	170,935	138,514
Loss from operations	(30,190)	(23,002)	(53,845)	(40,411)
Change in fair value of warrant liability	4,524	0	8,896	0
Interest expense	(4,419)	(62)	(6,203)	(72)
Interest and other income (expense), net	704	(391)	(1,089)	(260)
Loss before income taxes	(29,381)	(23,455)	(52,241)	(40,743)
Income tax provision	529	238	837	611
Net loss	(29,910)	(23,693)	(53,078)	(41,354)
Comprehensive loss:
Foreign currency translation adjustment	(316)	(174)	(675)	(259)
Unrealized loss on available-for-sale securities	(278)	0	(676)	(34)
Comprehensive loss	$ (30,504)	$ (23,867)	$ (54,429)	$ (41,647)
Net loss per share, basic (in dollars per share)	$ (0.23)	$ (0.19)	$ (0.41)	$ (0.34)
Net loss per share, diluted (in dollars per share)	$ (0.23)	$ (0.19)	$ (0.41)	$ (0.34)
Weighted-average shares outstanding used in calculating net loss per share, basic (in shares)	130,280	123,134	129,384	122,259
Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares)	130,280	123,134	129,384	122,259
Subscription
Revenue:
Total revenue	$ 83,811	$ 71,498	$ 162,311	$ 136,640
Cost of revenue:
Total cost of revenue	19,572	17,268	38,297	32,911
Professional services
Revenue:
Total revenue	14,964	14,989	29,663	30,176
Cost of revenue:
Total cost of revenue	$ 19,077	$ 18,724	$ 36,587	$ 35,802

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B common stock	Common Stock Class A common stock	Common Stock Class B common stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021				109,900	11,004
Beginning balance at Jan. 31, 2021	$ 171,913			$ 11	$ 1	$ 635,127	$ 796	$ (464,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				3,111	(3,111)
Issuance of common stock upon exercise of stock options (in shares)				313	1,204
Issuance of common stock upon exercise of stock options	10,187			$ 1		10,186
Lapse of restrictions on common stock related to early exercise of stock options	18					18
RSU releases (in shares)				1,539	26
Purchase of common stock under the ESPP (in shares)				388
Purchases of common stock under the ESPP	4,005					4,005
Charitable donation of stock (in shares)				61
Charitable donation of stock	1,000					1,000
Stock-based compensation	31,866					31,866
Other comprehensive loss	(293)						(293)
Net loss	(41,354)							(41,354)
Ending balance (in shares) at Jul. 31, 2021				115,312	9,123
Ending balance at Jul. 31, 2021	177,342			$ 12	$ 1	682,202	503	(505,376)
Beginning balance (in shares) at Apr. 30, 2021				111,249	10,955
Beginning balance at Apr. 30, 2021	171,507			$ 11	$ 1	652,501	677	(481,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				2,431	(2,431)
Issuance of common stock upon exercise of stock options (in shares)				274	593
Issuance of common stock upon exercise of stock options	6,620			$ 1		6,619
Lapse of restrictions on common stock related to early exercise of stock options	8					8
RSU releases (in shares)				909	6
Purchase of common stock under the ESPP (in shares)				388
Purchases of common stock under the ESPP	4,005					4,005
Charitable donation of stock (in shares)				61
Charitable donation of stock	1,000					1,000
Stock-based compensation	18,069					18,069
Other comprehensive loss	(174)						(174)
Net loss	(23,693)							(23,693)
Ending balance (in shares) at Jul. 31, 2021				115,312	9,123
Ending balance at Jul. 31, 2021	177,342			$ 12	$ 1	682,202	503	(505,376)
Beginning balance (in shares) at Jan. 31, 2022				119,008	9,048
Beginning balance at Jan. 31, 2022	$ 170,607			$ 12	$ 1	734,149	(108)	(563,447)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				1,165	(1,165)
Issuance of common stock upon exercise of stock options (in shares)	288			49	239
Issuance of common stock upon exercise of stock options	$ 1,522					1,522
RSU releases (in shares)				2,895
Purchase of common stock under the ESPP (in shares)				615
Purchases of common stock under the ESPP	4,485					4,485
Charitable donation of stock (in shares)				101
Charitable donation of stock	1,000					1,000
Stock-based compensation	51,038					51,038
Issuance of warrants	18,442					18,442
Other comprehensive loss	(1,351)						(1,351)
Net loss	(53,078)							(53,078)
Ending balance (in shares) at Jul. 31, 2022		123,800	8,100	123,833	8,122
Ending balance at Jul. 31, 2022	192,665			$ 12	$ 1	810,636	(1,459)	(616,525)
Beginning balance (in shares) at Apr. 30, 2022				121,133	8,014
Beginning balance at Apr. 30, 2022	188,856			$ 12	$ 1	776,323	(865)	(586,615)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				45	(45)
Issuance of common stock upon exercise of stock options (in shares)					153
Issuance of common stock upon exercise of stock options	615					615
RSU releases (in shares)				1,939
Purchase of common stock under the ESPP (in shares)				615
Purchases of common stock under the ESPP	4,485					4,485
Charitable donation of stock (in shares)				101
Charitable donation of stock	1,000					1,000
Stock-based compensation	28,213					28,213
Other comprehensive loss	(594)						(594)
Net loss	(29,910)							(29,910)
Ending balance (in shares) at Jul. 31, 2022		123,800	8,100	123,833	8,122
Ending balance at Jul. 31, 2022	$ 192,665			$ 12	$ 1	$ 810,636	$ (1,459)	$ (616,525)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net loss	$ (53,078)	$ (41,354)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation, amortization and accretion	8,882	8,496
Stock-based compensation	51,038	31,866
Provision for credit losses	1,134	1,368
Donation of common stock to charitable foundation	1,000	1,000
Amortization of deferred commissions	9,346	7,859
Reduction in carrying amount of right-of-use assets	4,070	4,760
Change in fair value of warrant liability	(8,896)	0
Other	267	426
Changes in operating assets and liabilities:
Accounts receivable	13,436	21,253
Prepaid expenses and other assets	(2,823)	(3,216)
Deferred commissions	(10,629)	(8,193)
Accounts payable	692	1,513
Accrued expenses and other liabilities	1,848	51
Accrued employee liabilities	(3,228)	(2,088)
Deferred revenue	(4,404)	(9,203)
Operating lease liabilities	(6,473)	(6,910)
Net cash provided by operating activities	2,182	7,628
Cash flows from investing activities:
Purchases of property and equipment	(6,084)	(3,697)
Insurance proceeds for damaged property and equipment	0	344
Purchase of intangible assets	0	(1,349)
Purchases of short-term investments	(195,685)	(53,650)
Maturities of short-term investments	55,263	49,492
Net cash used in investing activities	(146,506)	(8,860)
Cash flows from financing activities:
Proceeds from issuance of convertible senior notes, net of issuance costs	233,901	0
Proceeds from issuance of common stock upon exercise of stock options	1,522	10,187
Proceeds from issuance of common stock under employee stock purchase plan	4,485	4,005
Principal payments on debt	(1,480)	(2,222)
Net cash provided by financing activities	238,428	11,970
Effect of exchange rates on cash and cash equivalents	(675)	(259)
Net increase in cash and cash equivalents	93,429	10,479
Cash and cash equivalents, beginning of period	113,507	94,110
Cash and cash equivalents, end of period	206,936	104,589
Supplemental disclosure of non-cash investing and financing activities:
Lapse in restrictions on early exercised common stock options	0	18
Property and equipment purchases accrued or in accounts payable	322	44
Purchase of intangible assets included in accrued expenses and other current liabilities	$ 0	$ 225

Overview and Basis of Presentat

Overview and Basis of Presentation	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Note 1. Overview and Basis of Presentation Description of Business Zuora, Inc. was incorporated in the state of Delaware in 2006 and began operations in 2007. Zuora’s fiscal year ends on January 31. Zuora is headquartered in Redwood City, California. Zuora provides a cloud-based subscription management platform, built to help companies monetize new services and operate dynamic, recurring revenue business models. Our solution enables companies across multiple industries and geographies to launch, manage and scale a subscription business, automating the entire quote-to-cash and revenue recognition process, including quoting, billing, collections and revenue recognition. With Zuora’s solution, businesses can change pricing and packaging for products and services to grow and scale, efficiently comply with revenue recognition standards, analyze customer data to optimize their subscription offerings, and build meaningful relationships with their subscribers. References to “Zuora”, “us”, “our”, or “we” in these notes refer to Zuora, Inc. and its subsidiaries on a consolidated basis. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Zuora and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. All intercompany balances and transactions have been eliminated in consolidation. The unaudited condensed consolidated balance sheet as of January 31, 2022 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of comprehensive loss, statements of cash flows and statements of stockholders' equity for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2023 or any future period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022, filed with the SEC on March 28, 2022 (Annual Report). Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates. Our most significant estimates and assumptions are related to revenue recognition with respect to the determination of the relative standalone selling prices for our services; the expected period of benefit over which deferred commissions are amortized; valuation of stock-based awards and warrants; estimates of allowance for credit losses; estimates of the fair value of goodwill and long-lived assets when evaluating for impairments; useful lives of intangibles and other long-lived assets; and the valuation of deferred income tax assets and contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results may differ materially from these estimates under different assumptions or conditions.

Summary of Significant Accounti

Summary of Significant Accounting Policies and Recent Accounting Pronouncements	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies and Recent Accounting Pronouncements	Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements Our significant accounting policies are discussed in Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements in our Annual Report for the fiscal year ended January 31, 2022. There have been no significant changes to these policies during the six months ended July 31, 2022, except for updates resulting from our issuance to Silver Lake of the Initial Notes and Warrants (as defined in Note 9. Debt below) in March 2022, as discussed below. Additional information regarding our issuance of these convertible notes and warrants is included in Note 9. Debt and Note 17. Warrants to Purchase Shares of Common Stock, respectively. Derivative Financial Instruments The accounting treatment of derivative financial instruments requires that we record certain embedded features and warrants as assets or liabilities at their fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date with any change in fair value recorded as income or expense. In connection with our issuance of of the Initial Notes to Silver Lake on March 24, 2022, we adopted a sequencing policy in accordance with ASC 815-40 whereby financial instruments issued will be ordered by conversion or exercise price. Deferred Debt Issuance Costs Costs directly associated with obtaining debt financing are deferred and amortized using the effective interest rate method over the expected term of the related debt agreement. We determine the expected term of debt agreements by assessing the contractual term of the debt as well as any non-contingent put rights provided to the lenders. Unamortized amounts related to long-term debt are reflected on the unaudited condensed consolidated balance sheets as a direct deduction from the carrying amounts of the related long-term debt liability. Amortization expense of deferred loan costs was approximately $1.9 million and $2.7 million for the three and six months ended July 31, 2022, respectively, and is included in Interest expense on the accompanying unaudited condensed consolidated statements of comprehensive loss. Earnings per Share Basic earnings per share (EPS) is calculated by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period without consideration for common stock equivalents. Diluted EPS is computed by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period and the weighted average number of dilutive common stock equivalents outstanding for the period determined using the if-converted (convertible debt instruments) or treasury-stock method (warrants and share-based payment arrangements). For purposes of this calculation, common stock issuable upon conversion of debt, options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share when their effect is dilutive. Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models previously required under U.S. GAAP, including the beneficial conversion feature and cash conversion models. This ASU also simplifies the diluted earnings per share calculation in certain areas. The standard was effective for us beginning February 1, 2022 and we utilized the modified retrospective transition method of adoption. The adoption of this standard had no impact on our retained earnings or other components of equity as of the February 1, 2022 adoption date and had no impact to our earnings per share during the period of adoption.

Investments

Investments	6 Months Ended
	Jul. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Note 3. Investments The amortized costs, unrealized gains and losses and estimated fair values of our short-term investments were as follows (in thousands): July 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 64,533 $ 9 $ (543) $ 63,999 Corporate bonds 51,889 — (296) 51,593 Commercial paper 112,149 — — 112,149 Supranational bonds 9,995 — (12) 9,983 Foreign government securities 4,043 — (60) 3,983 Total short-term investments $ 242,609 $ 9 $ (911) $ 241,707 January 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 18,082 $ — $ (155) $ 17,927 Corporate bonds 21,225 — (49) 21,176 Commercial paper 55,234 — — 55,234 Supranational bonds 3,503 — — 3,503 Foreign government securities 4,064 — (22) 4,042 Total short-term investments $ 102,108 $ — $ (226) $ 101,882 There were no material realized gains or losses from sales of marketable securities that were reclassified out of accumulated other comprehensive loss into investment income during the three and six months ended July 31, 2022 and 2021. We had no significant unrealized losses on our available-for-sale securities as of July 31, 2022 and January 31, 2022, and we do not expect material credit losses on our current investments in future periods. All securities had stated effective maturities of less than one year as of July 31, 2022.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 4. Fair Value Measurements The accounting guidance for fair value measurements establishes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level input Input definition Level 1 Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability through corroboration with market data at the measurement date Level 3 Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date In general, and where applicable, we use quoted prices in active markets for identical assets or liabilities to determine fair value. If quoted prices in active markets for identical assets or liabilities are not available to determine fair value, then we use quoted prices for similar assets and liabilities or inputs other than the quoted prices that are observable either directly or indirectly. The following tables summarize our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis (in thousands): July 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 180,072 $ — $ — $ 180,072 Short-term investments: U.S. government securities $ — $ 63,999 $ — $ 63,999 Corporate bonds — 51,593 — 51,593 Commercial paper — 112,149 — 112,149 Supranational bonds — 9,983 — 9,983 Foreign government securities — 3,983 — 3,983 Total short-term investments $ — $ 241,707 $ — $ 241,707 Liabilities: Warrant liability $ — $ — $ 3,147 $ 3,147 January 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 92,668 $ — $ — $ 92,668 Short-term investments: U.S. government securities $ — $ 17,927 $ — $ 17,927 Corporate bonds — 21,176 — 21,176 Commercial paper — 55,234 — 55,234 Supranational bonds — 3,503 — 3,503 Foreign government securities — 4,042 — 4,042 Total short-term investments $ — $ 101,882 $ — $ 101,882 Changes in our Level 3 fair value measurements were as follows (in thousands): Level 3 Fair Value Balance, January 31, 2022 $ — Issuances 12,043 Settlements — Gain on change in fair value (8,896) Balance, July 31, 2022 $ 3,147 The carrying amounts of certain financial instruments, including cash held in bank accounts, accounts receivable, accounts payable, and accrued expenses, approximate fair value due to their relatively short maturities. The carrying amount of debt outstanding under the Initial Notes approximates fair value as of July 31, 2022. Additional information regarding the Initial Notes and Warrant liability is included in Note 9. Debt and Note 17. Warrants to Purchase Shares of Common Stock

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	6 Months Ended
	Jul. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	Note 5. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2022 January 31, 2022 Prepaid software subscriptions $ 5,896 $ 6,854 Prepaid insurance 4,756 3,220 Taxes 1,486 1,270 Contract assets 1,299 1,289 Prepaid hosting costs 1,245 767 Other 4,169 2,203 Total $ 18,851 $ 15,603

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Jul. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Note 6. Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): July 31, 2022 January 31, 2022 Software $ 30,383 $ 25,495 Leasehold improvements 17,073 17,277 Computer equipment 15,771 14,746 Furniture and fixtures 4,335 4,424 67,562 61,942 Less accumulated depreciation and amortization (38,067) (34,266) Total $ 29,495 $ 27,676 The following table summarizes the capitalized internal-use software costs included within the Software line item in the table above (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Internal-use software costs capitalized during the period $ 2,247 $ 1,038 $ 4,149 $ 1,962 July 31, 2022 January 31, 2022 Total capitalized internal-use software, net of accumulated amortization $ 13,890 $ 11,534 The following table summarizes total depreciation and amortization expense related to property and equipment, including amortization of internal-use software, included in General and administrative and Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Total depreciation and amortization expense $ 2,186 $ 2,984 $ 4,367 $ 5,828

Purchased Intangible Assets

Purchased Intangible Assets	6 Months Ended
	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Purchased Intangible Assets	Note 7. Purchased Intangible Assets The following table summarizes the purchased intangible asset balances and activity (in thousands): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Balance, January 31, 2022 $ 14,467 $ (11,015) $ 3,452 Amortization expense — (926) (926) Balance, July 31, 2022 $ 14,467 $ (11,941) $ 2,526 The following table summarizes amortization expense related to purchased intangible assets included in Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Purchased intangible assets amortization expense $ 372 $ 519 $ 926 $ 942

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended
	Jul. 31, 2022
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Note 8. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2022 January 31, 2022 Accrued outside services and consulting $ 5,219 $ 3,712 Accrued hosting and third-party licenses 4,095 3,865 Warrant liability 3,147 — Accrued taxes 2,064 2,422 Accrued interest 850 — Other accrued expenses 3,796 4,226 Total $ 19,171 $ 14,225

Debt

Debt	6 Months Ended
	Jul. 31, 2022
Debt Disclosure [Abstract]
Debt	Note 9. Debt 2029 Notes On March 24, 2022 (Initial Closing Date), we issued convertible senior notes (Initial Notes) in the aggregate principal amount of $250.0 million pursuant to an investment agreement (Investment Agreement) and indenture agreement (Indenture) to certain entities affiliated with Silver Lake Alpine II, L.P. (Silver Lake). Pursuant to the Investment Agreement, additional convertible senior notes in the aggregate principal amount of $150.0 million (Additional Notes), (together with the Initial Notes, the “2029 Notes”) shall be issued to Silver Lake 18 months after the Initial Closing Date, with an earlier issuance upon our completion of a Material Acquisition that meets the conditions described in Section 2.02(a) of the Investment Agreement. In addition, in the event that a Change in Control (as defined in the Indenture) occurs prior to the Additional Notes being issued, the noteholder would have the right to receive, at the noteholder's election, the Additional Notes, a cash payment, or common stock, as described in Section 2.02(b) of the Investment Agreement. The Initial Notes and the Additional Notes, once issued, represent senior unsecured obligations of Zuora. As a condition of the Investment Agreement, we also issued warrants to Silver Lake to acquire up to 7.5 million shares of Class A common stock (Warrants), of which (i) up to 2.5 million Warrants are exercisable at $20.00 per share, (ii) up to 2.5 million Warrants are exercisable at $22.00 per share and (iii) up to 2.5 million Warrants are exercisable at $24.00 per share. The Warrants are exercisable for a period of seven years from the Initial Closing Date. The purchase price of the 2029 Notes is 98% of the par value. The 2029 Notes bear interest at a rate of 3.95% per annum, payable quarterly in cash, provided that we have the option to pay interest in kind at 5.50% per annum. If elected, any such paid in kind interest will be added to the principal balance at each quarterly interest payment date. The 2029 Notes will mature on March 31, 2029, subject to earlier conversion or redemption. The Initial Notes are convertible at Silver Lake’s option into shares of our Class A common stock at an initial conversion rate of 50.0 shares per $1,000 principal amount ($20.00 per share, representing 12.5 million shares of Class A common stock), subject to customary anti-dilution adjustments. Any 2029 Notes that are converted in connection with a Make-Whole Fundamental Change (as defined in the Indenture) are subject to an increase in the conversion price under certain circumstances. With certain exceptions, upon a Fundamental Change, the holders of the 2029 Notes may require that we repurchase all or part of the principal amount of the 2029 Notes at a purchase price equal to the principal amount and accrued but unpaid interest outstanding, plus the total sum of all remaining scheduled interest payments through the remainder of the term of the 2029 Notes, at the 5.50% paid in kind interest rate. At any time on or after the fifth anniversary of the Initial Closing Date, the holders of the 2029 Notes may require that we repurchase all or part of the principal amount of the Notes at a purchase price equal to the principal amount plus accrued interest through the date of repurchase. Upon certain events of default, the 2029 Notes may be declared due and payable (or will automatically become so under certain events of default), at a purchase price equal to the principal amount plus accrued interest through the date of repurchase. We have no right to redeem the 2029 Notes prior to maturity. Pursuant to the Investment Agreement, without our prior written consent, Silver Lake is restricted from converting any 2029 Note, exercising any Warrant or transferring any 2029 Note or Warrant to parties other than affiliates or members of Silver Lake (with certain limited exceptions) for 18 months following the Initial Closing Date, or if sooner, upon the consummation of any Change in Control (as defined in the Investment Agreement) or entry into a definitive agreement for a transaction that, if consummated, would result in a Change in Control. We determined that the Initial Notes arrangement consisted of three freestanding instruments: the Initial Notes, the Warrants and the loan commitment related to the Additional Notes. In addition, we evaluated the embedded features in the Initial Notes and identified certain embedded features which were not clearly and closely related to the Initial Notes and met the definition of a derivative, and therefore required bifurcation from the host contract. We determined that the fair value of these bifurcated derivatives was de minimis as of the Initial Closing Date and as of July 31, 2022. As further discussed in Note 17. Warrants to Purchase Shares of Common Stock , a portion of the Warrants issued were determined to require liability classification with the remaining Warrants eligible to be classified in stockholders’ equity. As such, we allocated the proceeds obtained from the Initial Notes first to the liability-classified Warrants and then, on a relative fair value basis, between the equity-classified Warrants and the Initial Notes. We incurred approximately $8.1 million of debt issuance costs associated with the 2029 Notes and Warrants. Of this amount, we allocated $7.1 million as a component of the discount on the 2029 Notes, $0.7 million against the proceeds allocated to the equity-classified Warrants and $0.3 million was allocated to the liability-classified Warrants and recorded to General and administrative expense in the accompanying unaudited condensed consolidated statements of comprehensive loss. The 2029 Notes debt discount is being amortized using the effective interest rate method over the five year expected life of the 2029 Notes (representing the period from the contract date to the earliest noncontingent put date of May 24, 2027) and reflects an effective interest rate of 8.5%. The carrying value of the Initial Notes was classified as long-term and consisted of the following (in thousands): July 31, 2022 Initial Notes principal $ 250,000 Unamortized discount (43,574) Carrying value $ 206,426 Interest expense related to the Initial Notes, included in Interest expense in the accompanying unaudited condensed consolidated statements of comprehensive loss, was as follows (in thousands): Three Months Ended July 31, 2022 Six Months Ended July 31, 2022 Contractual interest expense $ 2,469 $ 3,484 Amortization of deferred loan costs 1,926 2,667 Total interest expense $ 4,395 $ 6,151 Debt Agreement We have an agreement with Silicon Valley Bank that includes a term and revolving loan facility, which is secured by a lien on substantially all of our non-IP assets (Debt Agreement). The interest rate under both the term and revolving loan facility is equal to the prime rate published by the Wall Street Journal minus 1.00%. The term loan facility, under which we borrowed $15.0 million in June 2017 to partially finance the acquisition of Leeyo Software, Inc., fully matured in June 2022. We made the final term loan principal and interest payment of $0.4 million during the three months ended July 31, 2022, and paid a fee of 1.5% of the original principal amount of the term loan facility, or $225,000, upon termination of the facility.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Note 10. Deferred Revenue and Performance Obligations The following table summarizes revenue recognized during the period that was included in the deferred revenue balance at the beginning of each respective period (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Revenue recognized from deferred revenue $ 77,680 $ 67,740 $ 115,461 $ 99,405 As of July 31, 2022, total remaining non-cancellable performance obligations under our subscription contracts with customers was approximately $457.4 million and we expect to recognize revenue on approximately $258.0 million of these remaining performance obligations over the next 12 months. Remaining performance obligations under our professional services contracts as of July 31, 2022 were not material.

Geographical Information

Geographical Information	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Geographical Information	Note 11. Geographical Information Disaggregation of Revenue Revenue by country, based on the customer’s address at the time of sale, was as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 United States $ 64,808 $ 55,967 $ 124,227 $ 105,674 Others 33,967 30,520 67,747 61,142 Total $ 98,775 $ 86,487 $ 191,974 $ 166,816 Percentage of revenue by geographic area: United States 66 % 65 % 65 % 63 % Other 34 % 35 % 35 % 37 % Other than the United States, no individual country exceeded 10% of total revenue for the three and six months ended July 31, 2022 and 2021. Long-lived assets Long-lived assets, which consist of property and equipment, net, deferred commissions, purchased intangible assets, net and operating lease right-of-use assets by geographic location, are based on the location of the legal entity that owns the asset. As of July 31, 2022 and 2021, no individual country exceeded 10% of total long-lived assets other than the United States.

Leases

Leases	6 Months Ended
	Jul. 31, 2022
Leases [Abstract]
Leases	Note 12. Leases We have non-cancelable operating leases for our offices located in the U.S. and abroad. As of July 31, 2022, these leases expire on various dates between 2023 and 2030. Certain lease agreements include one or more options to renew, with renewal terms that can extend the lease up to seven years. We have the right to exercise or forego the lease renewal options. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. The components of our long-term operating leases and related operating lease cost were as follows (in thousands): July 31, 2022 January 31, 2022 Operating lease right-of-use assets $ 28,573 $ 32,643 Operating lease liabilities, current portion $ 10,327 $ 11,462 Operating lease liabilities, net of current portion 41,533 45,633 Total operating lease liabilities $ 51,860 $ 57,095 Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Operating lease cost 1 $ 2,618 $ 3,164 $ 5,252 $ 6,380 (1) Includes costs related to our short-term operating leases as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Short-term operating lease costs $ 109 $ 101 $ 199 $ 203 The future maturities of long-term operating lease liabilities for each fiscal year were as follows (in thousands): Maturities of Operating Lease Liabilities 2023 (remainder of the year) $ 7,467 2024 10,988 2025 6,386 2026 6,242 2027 6,429 Thereafter 23,468 Total lease payments 60,980 Less imputed interest (9,120) Present value of lease liabilities $ 51,860 Other supplemental information related to our long-term operating leases includes the following (dollars in thousands): July 31, 2022 January 31, 2022 Weighted-average remaining operating lease term 6.8 years 7.0 years Weighted-average operating lease discount rate 4.6 % 4.6 % Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Supplemental Cash Flow Information Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases $ 3,408 $ 3,454 $ 6,822 $ 6,863 New right-of-use assets obtained in exchange for lease liabilities: Operating leases obtained $ — $ — $ — $ 3,923

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13. Commitments and Contingencies Letters of Credit In connection with the execution of certain facility leases, we had bank issued irrevocable letters of credit for $4.5 million as of July 31, 2022 and January 31, 2022. No draws have been made under such letters of credit. Legal Proceedings From time to time, we may be subject to legal proceedings, as well as demands, claims and threatened litigation. The outcomes of legal proceedings and other contingencies are inherently unpredictable, subject to significant uncertainties, and could be material to our operating results and cash flows for a particular period. Regardless of the outcome, litigation can have an adverse impact on our business because of defense and settlement costs, diversion of management resources, and other factors. Other than the matters described below, we are not currently party to any legal proceeding that we believe could have a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation or claim be resolved unfavorably. Securities Class Actions In June 2019, a putative securities class action lawsuit was filed in the U.S. District Court for the Northern District of California naming Zuora and certain of its officers as defendants. The complaint purports to bring suit on behalf of stockholders who purchased or otherwise acquired Zuora's securities between April 12, 2018 and May 30, 2019. The complaint alleges that defendants made false and misleading statements about Zuora's business, operations and prospects in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended (Exchange Act), and seeks unspecified compensatory damages, fees and costs. In November 2019, the lead plaintiff filed a consolidated amended complaint asserting the same claims. In April 2020, the court denied defendants’ motion to dismiss. On March 15, 2021, the court granted plaintiff’s motion to certify a class consisting of persons and entities who purchased or acquired Zuora common stock between April 12, 2018 and May 30, 2019 and who were allegedly damaged thereby. Discovery in this case is ongoing. In April and May 2020, two putative securities class action lawsuits were filed in the Superior Court of the State of California, County of San Mateo, naming as defendants Zuora and certain of its current and former officers, its directors and the underwriters of Zuora's initial public offering (IPO). The complaints purport to bring suit on behalf of stockholders who purchased or otherwise acquired Zuora's securities pursuant or traceable to the Registration Statement and Prospectus issued in connection with Zuora's IPO and allege claims under Sections 11, 12(a)(2) and 15 of the Securities Act of 1933. The suits seek unspecified damages and other relief. In July 2020, the court entered an order consolidating the two lawsuits, and the lead plaintiffs filed a consolidated amended complaint asserting the same claims. In October 2020, the court denied defendants ’ demurrer as to the Section 11 and Section 15 claims and granted the demurrer as to the Section 12(a)(2) claim with leave to file an amended complaint. In November 2020, the lead plaintiffs filed an amended consolidated complaint. Defendants' demurrer to the Section 12(a)(2) claim was sustained with leave to amend. On October 14, 2021, the court certified a class for the Section 11 and Section 15 claims, consisting of persons and entities who purchased or acquired Zuora common stock pursuant or traceable to the Registration Statement and Prospectus issued in connection with Zuora’s IPO. The lead plaintiffs voluntarily dismissed the Section 12(a)(2) claim without prejudice. Discovery in this case is ongoing. Given the procedural posture and the nature of such litigation matters, we are unable to estimate the reasonably possible loss or range of loss, if any, that may result from these matters. We dispute the claims described above and intend to vigorously defend against them. Derivative Litigation In September 2019, two stockholder derivative lawsuits were filed in the U.S. District Court for the Northern District of California against certain of Zuora’s directors and executive officers and naming Zuora as a nominal defendant. The derivative actions allege claims based on events similar to those in the securities class actions and assert causes of action against the individual defendants for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and for making false and misleading statements about Zuora's business, operations, and prospects in violation of Section 14(a) of the Exchange Act. Plaintiffs seek corporate reforms, unspecified damages and restitution, and fees and costs. In November 2019, the stockholder derivative lawsuits, which are related to the federal securities class action, were assigned to the same judge who is overseeing the federal securities class action lawsuit. In February 2020, the court entered an order consolidating the two derivative lawsuits. In May and June 2020, two stockholder derivative lawsuits were filed in the U.S. District Court for the District of Delaware against certain of Zuora’s directors and current and former executive officers. The derivative actions allege claims based on events similar to those in the securities class actions and the derivative actions pending in the Northern District of California and assert causes of action against the individual defendants for breach of fiduciary duty, unjust enrichment, waste of corporate assets, contribution, and for making false and misleading statements about Zuora’s business, operations, and prospects in violation of Section 14(a) of the Exchange Act. Plaintiff seeks corporate reforms, unspecified damages and restitution, and fees and costs. In June 2020, the court entered an order consolidating the two District of Delaware derivative lawsuits. In February and March 2021, two additional stockholder derivative lawsuits were filed in Delaware Chancery Court alleging similar claims based on the same underlying events. The two Chancery Court cases have been consolidated and an amended consolidated complaint has been filed. In May 2022, a stockholder derivative lawsuit was filed in the U.S. District Court for the Northern District of California against certain of Zuora’s directors and executive officers and naming Zuora as a nominal defendant. The derivative action alleges claims based on events similar to those in the securities class actions and asserts causes of action against the individual defendants for breach of fiduciary duty, waste of corporate assets, unjust enrichment, and contribution. Plaintiff seeks corporate reforms, unspecified damages and restitution, and fees and costs. The derivative lawsuits are currently stayed. Given the procedural posture and the nature of such litigation matters, we are unable to estimate the reasonably possible loss or range of loss, if any, that may result from these matters. Other Contractual Obligations As of July 31, 2022, we had a contractual obligation to make $45.9 million in purchases of cloud computing services provided by one of our vendors by September 30, 2024.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 14. Income Taxes The following table reflects our income tax provision, pretax loss and effective tax rate for the periods presented (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Loss before income taxes $ (29,381) $ (23,455) $ (52,241) $ (40,743) Income tax provision 529 238 837 611 Effective tax rate (1.8) % (1.0) % (1.6) % (1.5) %

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jul. 31, 2022
Equity [Abstract]
Stockholders' Equity	Note 15. Stockholders’ Equity Preferred Stock As of July 31, 2022, Zuora had authorized 10 million shares of preferred stock, each with a par value of $0.0001 per share. As of July 31, 2022, no shares of preferred stock were issued and outstanding. Common Stock Prior to Zuora's IPO, which was effective in April 2018, all shares of common stock then outstanding were reclassified into Class B common stock. Shares offered and sold in the IPO consisted of newly authorized shares of Class A common stock. Holders of Class A and Class B common stock are entitled to one vote per share and ten votes per share, respectively, and the shares of Class A common stock and Class B common stock are identical, except for voting rights and the right to convert Class B common stock to Class A common stock. As of July 31, 2022, Zuora had authorized 500 million shares of Class A common stock and 500 million shares of Class B common stock, each with a par value of $0.0001 per share. As of July 31, 2022, 123.8 million shares of Class A common stock and 8.1 million shares of Class B common stock were issued and outstanding. Accumulated Other Comprehensive Loss Components of accumulated other comprehensive loss were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Loss on Available-for-Sale Securities Total Balance, January 31, 2022 $ 118 $ (226) $ (108) Foreign currency translation adjustment (675) — (675) Unrealized loss on available-for-sale securities — (676) (676) Balance, July 31, 2022 $ (557) $ (902) $ (1,459) There were no material reclassifications out of accumulated other comprehensive loss during the three and six months ended July 31, 2022. Additionally, there was no material tax impact on the amounts presented.

Employee Stock Plans

Employee Stock Plans	6 Months Ended
	Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]
Employee Stock Plans	Note 16. Employee Stock Plans Equity Incentive Plans In March 2018, our Board of Directors adopted and our stockholders approved the 2018 Equity Incentive Plan (2018 Plan). The 2018 Plan authorizes the award of stock options, restricted stock awards, stock appreciation rights, restricted stock units (RSUs), performance awards, and stock bonuses. As of July 31, 2022, approximately 28.2 million shares of Class A common stock were reserved and available for issuance under the 2018 Plan. In addition, as of July 31, 2022, 4.4 million stock options and RSUs exercisable or settleable for Class B common stock were outstanding in the aggregate under our 2006 Stock Plan (2006 Plan) and 2015 Equity Incentive Plan (2015 Plan), which plans were terminated in May 2015 and April 2018, respectively. The 2006 Plan and 2015 Plan continue to govern outstanding equity awards granted thereunder. Stock Options The following tables summarize stock option activity and related information (in thousands, except weighted-average exercise price, weighted-average grant date fair value and average remaining contractual term): Shares Weighted-Average Average Aggregate Balance, January 31, 2022 8,560 $ 9.22 5.9 $ 67,259 Granted 20 12.52 Exercised (288) 5.31 Forfeited (194) 12.90 Balance, July 31, 2022 8,098 9.28 5.4 17,704 Exercisable as of July 31, 2022 4,408 4.49 3.5 17,704 Vested and expected to vest as of July 31, 2022 7,928 9.18 5.3 17,704 Three Months Ended July 31, Six Months Ended July 31, 2022 1 2021 2022 2021 Weighted-average grant date fair value per share of options granted during each respective period $ 5.54 $ 6.54 $ 5.54 $ 6.54 Aggregate intrinsic value of options exercised during each respective period $ 941 $ 8,147 $ 2,030 $ 14,738 We used the Black-Scholes option-pricing model to estimate the fair value of our stock options granted during each respective period using the following assumptions: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Fair value of common stock $ 12.52 $15.64 - $15.87 $ 12.52 $15.64 - $15.87 Expected volatility 42.6 % 42.6% - 42.7% 42.6 % 42.3% - 42.7% Expected term (years) 5.8 6.0 5.8 6.0 - 6.1 Risk-free interest rate 3.0 % 1.0% - 1.1% 3.0 % 1.0%- 1.1% Expected dividend yield — % — % — % — % RSUs The following table summarizes RSU activity and related information (in thousands, except weighted-average grant date fair value): Number of RSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2022 12,171 $ 15.46 Granted 6,886 12.84 Vested (2,895) 15.25 Forfeited (1,571) 14.24 Balance, July 31, 2022 14,591 14.40 Performance Stock Units (PSUs) In March 2022, we granted PSUs to certain executives under our 2018 Plan. Each grant is divided into three tranches, each tranche having pre-established performance targets that if met, as determined quarterly by our Compensation Committee, would result in the shares attributable to such tranche being earned, subject to a service-based vesting condition. The shares attributable to unearned tranches will be forfeited on January 31, 2025, if the applicable performance criteria for such tranches are not met. Stock-based compensation expense is recognized if it is probable the performance targets (for each respective tranche) will be met during the performance period. The following table summarizes PSU activity and related information (in thousands, except weighted-average grant date fair value): Number of PSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2022 — $ — Granted 2,905 15.21 Vested — — Forfeited — — Balance, July 31, 2022 2,905 15.21 2018 Employee Stock Purchase Plan In March 2018, our Board of Directors adopted and our stockholders approved the 2018 Employee Stock Purchase Plan (ESPP). This plan is broadly available to our employees in the United States and certain other countries in which we operate. A total of 4.6 million shares of Class A common stock were reserved and available for issuance under the ESPP as of July 31, 2022. The ESPP provides for 24-month offering periods beginning June 15 and December 15 of each year, and each offering period contains four six-month purchase periods. On each purchase date, ESPP participants will purchase shares of our Class A common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the Class A common stock on the offering date or (2) the fair market value of the Class A common stock on the purchase date. We estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: Three and Six Months Ended July 31, 2022 Three and Six Months Ended July 31, 2021 Fair value of common stock $ 8.91 $ 16.07 Expected volatility 44.4% - 52.3% 41.8% - 53.2% Expected term (years) 0.5 - 2.0 0.5 - 2.0 Risk-free interest rate 2.3% - 3.2% 0.1% - 0.2% Expected dividend yield — % — % Stock-Based Compensation Expense Stock-based compensation expense was recorded in the following cost and expense categories in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Cost of subscription revenue $ 2,281 $ 1,534 $ 4,080 $ 2,577 Cost of professional services revenue 3,690 2,664 6,707 4,665 Research and development 7,465 5,243 13,431 9,772 Sales and marketing 9,959 5,615 17,415 9,695 General and administrative 4,818 3,013 9,405 5,157 Total stock-based compensation expense $ 28,213 $ 18,069 $ 51,038 $ 31,866 As of July 31, 2022, unrecognized compensation costs related to unvested equity awards and the weighted-average remaining period over which those costs are expected to be recognized were as follows (dollars in thousands): Stock Options RSUs PSUs ESPP Unrecognized compensation costs $ 7,963 $ 172,767 $ 12,341 $ 9,120 Weighted-average remaining recognition period 2.1 years 2.4 years 2.1 years 1.3 years

Warrants to Purchase Shares of

Warrants to Purchase Shares of Common Stock	6 Months Ended
	Jul. 31, 2022
Other Liabilities Disclosure [Abstract]
Warrants to Purchase Shares of Common Stock	Note 17. Warrants to Purchase Shares of Common Stock In connection with the issuance of the 2029 Notes (discussed Note 9. Debt ), we issued to Silver Lake the Warrants to acquire up to 7.5 million shares of Class A common stock, exercisable for a period of approximately seven years from the Initial Closing Date, and of which (i) Warrants to purchase up to 2.5 million shares of Class A common stock are exercisable at $20.00 per share, (ii) Warrants to purchase up to 2.5 million shares of Class A common stock are exercisable at $22.00 per share and (iii) Warrants to purchase up to 2.5 million shares of Class A common stock are exercisable at $24.00 per share. In addition, Silver Lake can elect to exercise the Warrants on a net-exercise basis. If a Make-Whole Fundamental Change (as defined in the Form of Warrant) occurs, then the number of shares issuable upon exercise of the Warrants may be increased, and the exercise price for the Warrants adjusted. Beginning on the Initial Closing Date and ending on the earlier of (i) the date that is 18 months following the Initial Closing Date and (ii) the consummation of any Change in Control, except for certain limited exceptions, the Warrants are only exercisable with our written approval. As of July 31, 2022, all 7.5 million Warrants were outstanding. We have classified a portion of the Warrants as a current liability due to certain settlement provisions in the Warrants. Under certain Make-Whole Fundamental Change scenarios, we would be required to, at our option, either (i) obtain shareholder approval prior to issuing 20% or more of our outstanding common stock or (ii) pay cash in lieu of delivering any shares at or above such 20% threshold. As a result, we concluded that approximately 2.8 million Warrants valued at $12.0 million as of the Initial Closing Date do not qualify for equity classification under ASC 815-40, pursuant to our sequencing policy described in Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements. We will reassess the classification of the Warrant liability in future reporting periods to determine if any change is required. The Warrants were measured using the Black-Scholes option pricing model at the issuance date (Initial Closing Date) and the Warrant liability was remeasured using the same model as of July 31, 2022 using the following inputs: July 31, 2022 March 24, 2022 Fair value of common stock 1 $ 7.60 $ 13.77 Exercise price² $22.00 - $24.00 $22.00 - $24.00 Expected volatility 40.3 % 41.9 % Expected term (in years) 6.7 7.0 Risk-free interest rate 2.7 % 2.4 % Expected dividend yield — — ______________ (1) The fair value of common stock was adjusted to reflect certain restrictions on the Warrants for 18 months following the issuance date. (2) The range of exercise prices reflects the Warrants that were liability-classified. During the three and six months ended July 31, 2022, the liability-classified Warrants were revalued, resulting in a realized gain of $4.5 million and $8.9 million, respectively, which is included in Change in fair value of warrant liability in the accompanying unaudited condensed consolidated statements of comprehensive loss. Refer to Note 4. Fair Value Measurements for the fair value of the liability-classified Warrants.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Note 18. Net Loss Per Share The following table presents the calculation of basic and diluted net loss per share for the periods presented (in thousands, except per share data): Three Months Ended Six Months Ended 2022 2021 2022 2021 Numerator: Net loss $ (29,910) $ (23,693) $ (53,078) $ (41,354) Denominator: Weighted-average common shares outstanding, basic and diluted 130,280 123,134 129,384 122,259 Net loss per share, basic and diluted $ (0.23) $ (0.19) $ (0.41) $ (0.34) Since we were in a net loss position for all periods presented, basic net loss per share attributable to common stockholders is the same as diluted net loss per share, as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): July 31, 2022 2021 Initial Notes conversion 12,500 — Unvested RSUs issued and outstanding 14,591 12,845 Issued and outstanding stock options 8,098 10,142 Warrants 7,500 — Unvested PSUs issued and outstanding 2,905 — Shares committed under ESPP 208 144 Total 45,802 23,131

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 19. Subsequent Events On August 23, 2022, Zuora entered into an agreement to acquire Zephr Inc Limited (Zephr), a cloud-based subscription management platform provider. Under the agreement, the consideration will consist of approximately $44.0 million in cash paid at closing by Zuora (subject to customary adjustments for working capital, transaction expenses, cash and indebtedness). The foregoing excludes up to $6.0 million in an additional potential earnout payment tied to performance-based conditions if achieved by the Zephr business by January 31, 2023. We expect the acquisition to close in early September 2022, subject to customary closing conditions.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Zuora and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. All intercompany balances and transactions have been eliminated in consolidation. The unaudited condensed consolidated balance sheet as of January 31, 2022 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of comprehensive loss, statements of cash flows and statements of stockholders' equity for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2023 or any future period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022, filed with the SEC on March 28, 2022 (Annual Report).
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates. Our most significant estimates and assumptions are related to revenue recognition with respect to the determination of the relative standalone selling prices for our services; the expected period of benefit over which deferred commissions are amortized; valuation of stock-based awards and warrants; estimates of allowance for credit losses; estimates of the fair value of goodwill and long-lived assets when evaluating for impairments; useful lives of intangibles and other long-lived assets; and the valuation of deferred income tax assets and contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results may differ materially from these estimates under different assumptions or conditions.
Derivative Financial Instruments	Derivative Financial InstrumentsThe accounting treatment of derivative financial instruments requires that we record certain embedded features and warrants as assets or liabilities at their fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date with any change in fair value recorded as income or expense. In connection with our issuance of of the Initial Notes to Silver Lake on March 24, 2022, we adopted a sequencing policy in accordance with ASC 815-40 whereby financial instruments issued will be ordered by conversion or exercise price.
Deferred Debt Issuance Costs	Deferred Debt Issuance Costs Costs directly associated with obtaining debt financing are deferred and amortized using the effective interest rate method over the expected term of the related debt agreement. We determine the expected term of debt agreements by assessing the contractual term of the debt as well as any non-contingent put rights provided to the lenders. Unamortized amounts related to long-term debt are reflected on the unaudited condensed consolidated balance sheets as a direct deduction from the carrying amounts of the related long-term debt liability. Amortization expense of deferred loan costs was approximately $1.9 million and $2.7 million for the three and six months ended July 31, 2022, respectively, and is included in Interest expense on the accompanying unaudited condensed consolidated statements of comprehensive loss.
Earnings per Share	Earnings per ShareBasic earnings per share (EPS) is calculated by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period without consideration for common stock equivalents. Diluted EPS is computed by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period and the weighted average number of dilutive common stock equivalents outstanding for the period determined using the if-converted (convertible debt instruments) or treasury-stock method (warrants and share-based payment arrangements). For purposes of this calculation, common stock issuable upon conversion of debt, options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share when their effect is dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by removing certain separation models previously required under U.S. GAAP, including the beneficial conversion feature and cash conversion models. This ASU also simplifies the diluted earnings per share calculation in certain areas. The standard was effective for us beginning February 1, 2022 and we utilized the modified retrospective transition method of adoption. The adoption of this standard had no impact on our retained earnings or other components of equity as of the February 1, 2022 adoption date and had no impact to our earnings per share during the period of adoption.

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jul. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost, Unrealized Gains and Losses, and Estimated Fair Value of Short-term Investments	The amortized costs, unrealized gains and losses and estimated fair values of our short-term investments were as follows (in thousands): July 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 64,533 $ 9 $ (543) $ 63,999 Corporate bonds 51,889 — (296) 51,593 Commercial paper 112,149 — — 112,149 Supranational bonds 9,995 — (12) 9,983 Foreign government securities 4,043 — (60) 3,983 Total short-term investments $ 242,609 $ 9 $ (911) $ 241,707 January 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 18,082 $ — $ (155) $ 17,927 Corporate bonds 21,225 — (49) 21,176 Commercial paper 55,234 — — 55,234 Supranational bonds 3,503 — — 3,503 Foreign government securities 4,064 — (22) 4,042 Total short-term investments $ 102,108 $ — $ (226) $ 101,882

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Fair Value Hierarchy for Financial Assets Measured on a Recurring Basis	The following tables summarize our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis (in thousands): July 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 180,072 $ — $ — $ 180,072 Short-term investments: U.S. government securities $ — $ 63,999 $ — $ 63,999 Corporate bonds — 51,593 — 51,593 Commercial paper — 112,149 — 112,149 Supranational bonds — 9,983 — 9,983 Foreign government securities — 3,983 — 3,983 Total short-term investments $ — $ 241,707 $ — $ 241,707 Liabilities: Warrant liability $ — $ — $ 3,147 $ 3,147 January 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 92,668 $ — $ — $ 92,668 Short-term investments: U.S. government securities $ — $ 17,927 $ — $ 17,927 Corporate bonds — 21,176 — 21,176 Commercial paper — 55,234 — 55,234 Supranational bonds — 3,503 — 3,503 Foreign government securities — 4,042 — 4,042 Total short-term investments $ — $ 101,882 $ — $ 101,882
Schedule of Changes in Level 3 Fair Value Measurements	Changes in our Level 3 fair value measurements were as follows (in thousands): Level 3 Fair Value Balance, January 31, 2022 $ — Issuances 12,043 Settlements — Gain on change in fair value (8,896) Balance, July 31, 2022 $ 3,147

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	6 Months Ended
	Jul. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2022 January 31, 2022 Prepaid software subscriptions $ 5,896 $ 6,854 Prepaid insurance 4,756 3,220 Taxes 1,486 1,270 Contract assets 1,299 1,289 Prepaid hosting costs 1,245 767 Other 4,169 2,203 Total $ 18,851 $ 15,603

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Jul. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): July 31, 2022 January 31, 2022 Software $ 30,383 $ 25,495 Leasehold improvements 17,073 17,277 Computer equipment 15,771 14,746 Furniture and fixtures 4,335 4,424 67,562 61,942 Less accumulated depreciation and amortization (38,067) (34,266) Total $ 29,495 $ 27,676 The following table summarizes the capitalized internal-use software costs included within the Software line item in the table above (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Internal-use software costs capitalized during the period $ 2,247 $ 1,038 $ 4,149 $ 1,962 July 31, 2022 January 31, 2022 Total capitalized internal-use software, net of accumulated amortization $ 13,890 $ 11,534 The following table summarizes total depreciation and amortization expense related to property and equipment, including amortization of internal-use software, included in General and administrative and Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Total depreciation and amortization expense $ 2,186 $ 2,984 $ 4,367 $ 5,828

Purchased Intangible Assets (Ta

Purchased Intangible Assets (Tables)	6 Months Ended
	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Purchased Intangible Assets	The following table summarizes the purchased intangible asset balances and activity (in thousands): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Balance, January 31, 2022 $ 14,467 $ (11,015) $ 3,452 Amortization expense — (926) (926) Balance, July 31, 2022 $ 14,467 $ (11,941) $ 2,526
Schedule of Amortization Expense Related to Purchased Intangible Assets	The following table summarizes amortization expense related to purchased intangible assets included in Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Purchased intangible assets amortization expense $ 372 $ 519 $ 926 $ 942

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Jul. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2022 January 31, 2022 Accrued outside services and consulting $ 5,219 $ 3,712 Accrued hosting and third-party licenses 4,095 3,865 Warrant liability 3,147 — Accrued taxes 2,064 2,422 Accrued interest 850 — Other accrued expenses 3,796 4,226 Total $ 19,171 $ 14,225

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jul. 31, 2022
Debt Disclosure [Abstract]
Schedule of Carry Value of Long-term Debt	The carrying value of the Initial Notes was classified as long-term and consisted of the following (in thousands): July 31, 2022 Initial Notes principal $ 250,000 Unamortized discount (43,574) Carrying value $ 206,426
Schedule of Interest Expense	Interest expense related to the Initial Notes, included in Interest expense in the accompanying unaudited condensed consolidated statements of comprehensive loss, was as follows (in thousands): Three Months Ended July 31, 2022 Six Months Ended July 31, 2022 Contractual interest expense $ 2,469 $ 3,484 Amortization of deferred loan costs 1,926 2,667 Total interest expense $ 4,395 $ 6,151

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Tables)	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue Recognized that was Previously Included In Deferred Revenue	The following table summarizes revenue recognized during the period that was included in the deferred revenue balance at the beginning of each respective period (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Revenue recognized from deferred revenue $ 77,680 $ 67,740 $ 115,461 $ 99,405

Geographical Information (Table

Geographical Information (Tables)	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Country Based on Customer Address at Time of Sale	Revenue by country, based on the customer’s address at the time of sale, was as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 United States $ 64,808 $ 55,967 $ 124,227 $ 105,674 Others 33,967 30,520 67,747 61,142 Total $ 98,775 $ 86,487 $ 191,974 $ 166,816 Percentage of revenue by geographic area: United States 66 % 65 % 65 % 63 % Other 34 % 35 % 35 % 37 %

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jul. 31, 2022
Leases [Abstract]
Schedule of Components of Long-term Operating Leases	The components of our long-term operating leases and related operating lease cost were as follows (in thousands): July 31, 2022 January 31, 2022 Operating lease right-of-use assets $ 28,573 $ 32,643 Operating lease liabilities, current portion $ 10,327 $ 11,462 Operating lease liabilities, net of current portion 41,533 45,633 Total operating lease liabilities $ 51,860 $ 57,095
Schedule of Operating Lease Costs	Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Operating lease cost 1 $ 2,618 $ 3,164 $ 5,252 $ 6,380 (1) Includes costs related to our short-term operating leases as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Short-term operating lease costs $ 109 $ 101 $ 199 $ 203
Schedule of Maturities of Operating Lease Liabilities	The future maturities of long-term operating lease liabilities for each fiscal year were as follows (in thousands): Maturities of Operating Lease Liabilities 2023 (remainder of the year) $ 7,467 2024 10,988 2025 6,386 2026 6,242 2027 6,429 Thereafter 23,468 Total lease payments 60,980 Less imputed interest (9,120) Present value of lease liabilities $ 51,860
Schedule of Supplemental Operating Lease Information	Other supplemental information related to our long-term operating leases includes the following (dollars in thousands): July 31, 2022 January 31, 2022 Weighted-average remaining operating lease term 6.8 years 7.0 years Weighted-average operating lease discount rate 4.6 % 4.6 % Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Supplemental Cash Flow Information Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases $ 3,408 $ 3,454 $ 6,822 $ 6,863 New right-of-use assets obtained in exchange for lease liabilities: Operating leases obtained $ — $ — $ — $ 3,923

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Income Tax Provision, Pretax Loss, and Effective Tax Rate	The following table reflects our income tax provision, pretax loss and effective tax rate for the periods presented (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Loss before income taxes $ (29,381) $ (23,455) $ (52,241) $ (40,743) Income tax provision 529 238 837 611 Effective tax rate (1.8) % (1.0) % (1.6) % (1.5) %

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jul. 31, 2022
Equity [Abstract]
Schedule of Components of Accumulated Other Comprehensive Income	Components of accumulated other comprehensive loss were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Loss on Available-for-Sale Securities Total Balance, January 31, 2022 $ 118 $ (226) $ (108) Foreign currency translation adjustment (675) — (675) Unrealized loss on available-for-sale securities — (676) (676) Balance, July 31, 2022 $ (557) $ (902) $ (1,459)

Employee Stock Plans (Tables)

Employee Stock Plans (Tables)	6 Months Ended
	Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	The following tables summarize stock option activity and related information (in thousands, except weighted-average exercise price, weighted-average grant date fair value and average remaining contractual term): Shares Weighted-Average Average Aggregate Balance, January 31, 2022 8,560 $ 9.22 5.9 $ 67,259 Granted 20 12.52 Exercised (288) 5.31 Forfeited (194) 12.90 Balance, July 31, 2022 8,098 9.28 5.4 17,704 Exercisable as of July 31, 2022 4,408 4.49 3.5 17,704 Vested and expected to vest as of July 31, 2022 7,928 9.18 5.3 17,704
Schedule of Stock Option Grant Date Fair Value and Intrinsic Value of Options Exercised	Three Months Ended July 31, Six Months Ended July 31, 2022 1 2021 2022 2021 Weighted-average grant date fair value per share of options granted during each respective period $ 5.54 $ 6.54 $ 5.54 $ 6.54 Aggregate intrinsic value of options exercised during each respective period $ 941 $ 8,147 $ 2,030 $ 14,738
Schedule of Valuation Assumptions for Estimated Fair Value of Stock Options	We used the Black-Scholes option-pricing model to estimate the fair value of our stock options granted during each respective period using the following assumptions: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Fair value of common stock $ 12.52 $15.64 - $15.87 $ 12.52 $15.64 - $15.87 Expected volatility 42.6 % 42.6% - 42.7% 42.6 % 42.3% - 42.7% Expected term (years) 5.8 6.0 5.8 6.0 - 6.1 Risk-free interest rate 3.0 % 1.0% - 1.1% 3.0 % 1.0%- 1.1% Expected dividend yield — % — % — % — %
Schedule of RSU Activity	The following table summarizes RSU activity and related information (in thousands, except weighted-average grant date fair value): Number of RSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2022 12,171 $ 15.46 Granted 6,886 12.84 Vested (2,895) 15.25 Forfeited (1,571) 14.24 Balance, July 31, 2022 14,591 14.40
Schedule of PSU Activity	The following table summarizes PSU activity and related information (in thousands, except weighted-average grant date fair value): Number of PSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2022 — $ — Granted 2,905 15.21 Vested — — Forfeited — — Balance, July 31, 2022 2,905 15.21
Schedule of Valuation Assumptions for Estimated Fair Value of ESPP	We estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: Three and Six Months Ended July 31, 2022 Three and Six Months Ended July 31, 2021 Fair value of common stock $ 8.91 $ 16.07 Expected volatility 44.4% - 52.3% 41.8% - 53.2% Expected term (years) 0.5 - 2.0 0.5 - 2.0 Risk-free interest rate 2.3% - 3.2% 0.1% - 0.2% Expected dividend yield — % — %
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense was recorded in the following cost and expense categories in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Cost of subscription revenue $ 2,281 $ 1,534 $ 4,080 $ 2,577 Cost of professional services revenue 3,690 2,664 6,707 4,665 Research and development 7,465 5,243 13,431 9,772 Sales and marketing 9,959 5,615 17,415 9,695 General and administrative 4,818 3,013 9,405 5,157 Total stock-based compensation expense $ 28,213 $ 18,069 $ 51,038 $ 31,866
Schedule of Unrecognized Compensation Costs Related to Unvested Equity Awards	As of July 31, 2022, unrecognized compensation costs related to unvested equity awards and the weighted-average remaining period over which those costs are expected to be recognized were as follows (dollars in thousands): Stock Options RSUs PSUs ESPP Unrecognized compensation costs $ 7,963 $ 172,767 $ 12,341 $ 9,120 Weighted-average remaining recognition period 2.1 years 2.4 years 2.1 years 1.3 years

Warrants to Purchase Shares o_2

Warrants to Purchase Shares of Common Stock (Tables)	6 Months Ended
	Jul. 31, 2022
Other Liabilities Disclosure [Abstract]
Schedule of Fair Value Measurement Valuation Inputs	The Warrants were measured using the Black-Scholes option pricing model at the issuance date (Initial Closing Date) and the Warrant liability was remeasured using the same model as of July 31, 2022 using the following inputs: July 31, 2022 March 24, 2022 Fair value of common stock 1 $ 7.60 $ 13.77 Exercise price² $22.00 - $24.00 $22.00 - $24.00 Expected volatility 40.3 % 41.9 % Expected term (in years) 6.7 7.0 Risk-free interest rate 2.7 % 2.4 % Expected dividend yield — — ______________ (1) The fair value of common stock was adjusted to reflect certain restrictions on the Warrants for 18 months following the issuance date. (2) The range of exercise prices reflects the Warrants that were liability-classified.

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share for the periods presented (in thousands, except per share data): Three Months Ended Six Months Ended 2022 2021 2022 2021 Numerator: Net loss $ (29,910) $ (23,693) $ (53,078) $ (41,354) Denominator: Weighted-average common shares outstanding, basic and diluted 130,280 123,134 129,384 122,259 Net loss per share, basic and diluted $ (0.23) $ (0.19) $ (0.41) $ (0.34)
Schedule of Potential Dilutive Securities Not Included in the Diluted Per Share Calculations	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): July 31, 2022 2021 Initial Notes conversion 12,500 — Unvested RSUs issued and outstanding 14,591 12,845 Issued and outstanding stock options 8,098 10,142 Warrants 7,500 — Unvested PSUs issued and outstanding 2,905 — Shares committed under ESPP 208 144 Total 45,802 23,131

Summary of Significant Accoun_3

Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2022
Accounting Policies [Abstract]
Amortization of deferred loan costs	$ 1.9	$ 2.7

Investments - Amortized Cost to

Investments - Amortized Cost to Fair Value (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 242,609	$ 102,108
Gross Unrealized Gains	9	0
Gross Unrealized Losses	(911)	(226)
Fair Value	241,707	101,882
U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	64,533	18,082
Gross Unrealized Gains	9	0
Gross Unrealized Losses	(543)	(155)
Fair Value	63,999	17,927
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	51,889	21,225
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(296)	(49)
Fair Value	51,593	21,176
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	112,149	55,234
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	112,149	55,234
Supranational bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	9,995	3,503
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(12)	0
Fair Value	9,983	3,503
Foreign government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	4,043	4,064
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(60)	(22)
Fair Value	$ 3,983	$ 4,042

Investments - Narrative (Detail

Investments - Narrative (Details)	Jul. 31, 2022
Maximum
Debt Securities, Available-for-sale [Line Items]
Securities stated effective maturities (in years)	1 year

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurements on a Recurring Basis (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Short-term investments:
Short-term investments	$ 241,707	$ 101,882
U.S. government securities
Short-term investments:
Short-term investments	63,999	17,927
Corporate bonds
Short-term investments:
Short-term investments	51,593	21,176
Commercial paper
Short-term investments:
Short-term investments	112,149	55,234
Supranational bonds
Short-term investments:
Short-term investments	9,983	3,503
Foreign government securities
Short-term investments:
Short-term investments	3,983	4,042
Recurring
Short-term investments:
Short-term investments	241,707	101,882
Recurring | Money market funds
Cash equivalents:
Cash equivalents	180,072	92,668
Recurring | U.S. government securities
Short-term investments:
Short-term investments	63,999	17,927
Recurring | Corporate bonds
Short-term investments:
Short-term investments	51,593	21,176
Recurring | Commercial paper
Short-term investments:
Short-term investments	112,149	55,234
Recurring | Supranational bonds
Short-term investments:
Short-term investments	9,983	3,503
Recurring | Foreign government securities
Short-term investments:
Short-term investments	3,983	4,042
Recurring | Warrant liability
Liabilities:
Warrant liability	3,147
Recurring | Level 1
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Money market funds
Cash equivalents:
Cash equivalents	180,072	92,668
Recurring | Level 1 | U.S. government securities
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Corporate bonds
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Commercial paper
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Supranational bonds
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Foreign government securities
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Warrant liability
Liabilities:
Warrant liability	0
Recurring | Level 2
Short-term investments:
Short-term investments	241,707	101,882
Recurring | Level 2 | Money market funds
Cash equivalents:
Cash equivalents	0	0
Recurring | Level 2 | U.S. government securities
Short-term investments:
Short-term investments	63,999	17,927
Recurring | Level 2 | Corporate bonds
Short-term investments:
Short-term investments	51,593	21,176
Recurring | Level 2 | Commercial paper
Short-term investments:
Short-term investments	112,149	55,234
Recurring | Level 2 | Supranational bonds
Short-term investments:
Short-term investments	9,983	3,503
Recurring | Level 2 | Foreign government securities
Short-term investments:
Short-term investments	3,983	4,042
Recurring | Level 2 | Warrant liability
Liabilities:
Warrant liability	0
Recurring | Level 3
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Money market funds
Cash equivalents:
Cash equivalents	0	0
Recurring | Level 3 | U.S. government securities
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Corporate bonds
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Commercial paper
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Supranational bonds
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Foreign government securities
Short-term investments:
Short-term investments	0	$ 0
Recurring | Level 3 | Warrant liability
Liabilities:
Warrant liability	$ 3,147

Fair Value Measurements - Chang

Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details) - Warrant liability $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Changes in Level 3 Fair Value Measurements
Beginning balance	$ 0
Issuances	12,043
Settlements	0
Gain on change in fair value	(8,896)
Ending balance	$ 3,147

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Prepaid expenses and other current assets
Prepaid software subscriptions	$ 5,896	$ 6,854
Prepaid insurance	4,756	3,220
Taxes	1,486	1,270
Contract assets	1,299	1,289
Prepaid hosting costs	1,245	767
Other	4,169	2,203
Total	$ 18,851	$ 15,603

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Property and Equipment [Line Items]
Property and equipment, gross	$ 67,562	$ 61,942
Less accumulated depreciation and amortization	(38,067)	(34,266)
Total	29,495	27,676
Software
Property and Equipment [Line Items]
Property and equipment, gross	30,383	25,495
Leasehold improvements
Property and Equipment [Line Items]
Property and equipment, gross	17,073	17,277
Computer equipment
Property and Equipment [Line Items]
Property and equipment, gross	15,771	14,746
Furniture and fixtures
Property and Equipment [Line Items]
Property and equipment, gross	$ 4,335	$ 4,424

Property and Equipment, Net - C

Property and Equipment, Net - Capitalized Internal-use Software Costs (Details) - Internal-use software - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Property and Equipment [Line Items]
Internal-use software costs capitalized during the period	$ 2,247	$ 1,038	$ 4,149	$ 1,962
Total capitalized internal-use software, net of accumulated amortization	$ 13,890		$ 13,890		$ 11,534

Property and Equipment, Net - D

Property and Equipment, Net - Depreciation and Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
Total depreciation and amortization expense	$ 2,186	$ 2,984	$ 4,367	$ 5,828

Purchased Intangible Assets - S

Purchased Intangible Assets - Summary (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Purchased Intangible Assets
Gross Carrying Amount	$ 14,467		$ 14,467		$ 14,467
Accumulated Amortization	(11,941)		(11,941)		(11,015)
Net Carrying Amount	2,526		2,526		$ 3,452
Amortization expense	$ (372)	$ (519)	$ (926)	$ (942)

Purchased Intangible Assets - A

Purchased Intangible Assets - Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Purchased intangible assets amortization expense	$ 372	$ 519	$ 926	$ 942

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Payables and Accruals [Abstract]
Accrued outside services and consulting	$ 5,219	$ 3,712
Accrued hosting and third-party licenses	4,095	3,865
Warrant liability	3,147	0
Accrued taxes	2,064	2,422
Accrued interest	850	0
Other accrued expenses	3,796	4,226
Total	$ 19,171	$ 14,225

Debt - Narrative (Details)

Debt - Narrative (Details) $ / shares in Units, shares in Millions, converted_share in Millions		1 Months Ended	3 Months Ended	6 Months Ended
	Mar. 24, 2022 USD ($) freestanding_instrument converted_share $ / shares shares	Jun. 30, 2017 USD ($)	Jul. 31, 2022 USD ($) shares	Jul. 31, 2022 USD ($) shares
Debt Instrument [Line Items]
Debt issuance costs				$ 8,100,000
Silicon Valley Bank Debt Agreement | WSJ Prime Rate
Debt Instrument [Line Items]
Basis spread on variable interest rate, minus (percent)				1%
Silicon Valley Bank Debt Agreement | Revolving Loan
Debt Instrument [Line Items]
Credit facility maximum borrowing capacity			$ 30,000,000	$ 30,000,000
Amount drawn under credit facility			$ 0	$ 0
Silver Lake Warrants
Debt Instrument [Line Items]
Number of securities called by warrants (in shares) | shares	7.5		7.5	7.5
Warrants term	7 years
Silver Lake Warrants | Warrants, tranche one
Debt Instrument [Line Items]
Number of securities called by warrants (in shares) | shares	2.5
Exercise price of warrants (in dollars per share) | $ / shares	$ 20
Silver Lake Warrants | Warrants, tranche two
Debt Instrument [Line Items]
Number of securities called by warrants (in shares) | shares	2.5
Exercise price of warrants (in dollars per share) | $ / shares	$ 22
Silver Lake Warrants | Warrants, tranche three
Debt Instrument [Line Items]
Number of securities called by warrants (in shares) | shares	2.5
Exercise price of warrants (in dollars per share) | $ / shares	$ 24
Equity-classified warrants
Debt Instrument [Line Items]
Debt issuance costs				$ 700,000
Liability-classified warrants
Debt Instrument [Line Items]
Debt issuance costs				300,000
Term loan | Silicon Valley Bank Debt Agreement
Debt Instrument [Line Items]
Proceeds from term loan		$ 15,000,000
Balance on term loan			$ 400,000	400,000
Prepayment or termination fee (percent)			1.50%
Amount due per agreement upon prepayment or termination of facility			$ 225,000
2029 Notes | Convertible senior notes
Debt Instrument [Line Items]
Conversion percentage of par value	98%
Interest rate (percent)	3.95%
Optional in kind interest (percent)	5.50%
Period for conversion restrictions	18 months
Number of freestanding instruments | freestanding_instrument	3
Debt issuance costs				7,100,000
Debt discount amortization period	5 years
Effective interest rate (percent)	8.50%
Initial Notes | Convertible senior notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 250,000,000
Initial conversion rate	50
Principal amount for conversion	$ 1,000
Price per share conversion (in dollars per share) | $ / shares	$ 20
Number of equity instruments upon conversion (in shares) | converted_share	12.5
Balance on term loan			$ 206,426,000	$ 206,426,000
Additional Notes | Convertible senior notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 150,000,000
Period for issuance of additional notes	18 months

Debt - Balances (Details)

Debt - Balances (Details) - Initial Notes - Convertible senior notes $ in Thousands	Jul. 31, 2022 USD ($)
Debt Instrument [Line Items]
Initial Notes principal	$ 250,000
Unamortized discount	(43,574)
Carrying value	$ 206,426

Debt - Interest expense (Detail

Debt - Interest expense (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2022
Interest Expenses [Line Items]
Amortization of deferred loan costs	$ 1,900	$ 2,700
Initial Notes | Convertible senior notes
Interest Expenses [Line Items]
Contractual interest expense	2,469	3,484
Amortization of deferred loan costs	1,926	2,667
Total interest expense	$ 4,395	$ 6,151

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Deferred Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue recognized from deferred revenue	$ 77,680	$ 67,740	$ 115,461	$ 99,405

Deferred Revenue and Performa_4

Deferred Revenue and Performance Obligations - Narrative (Details) $ in Millions	Jul. 31, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 457.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 258
Revenue, remaining performance obligation, period	12 months

Geographical Information (Detai

Geographical Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 98,775	$ 86,487	$ 191,974	$ 166,816
United States
Disaggregation of Revenue [Line Items]
Revenue	64,808	55,967	124,227	105,674
Others
Disaggregation of Revenue [Line Items]
Revenue	$ 33,967	$ 30,520	$ 67,747	$ 61,142
Revenue | Geographic concentration | United States
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	66%	65%	65%	63%
Revenue | Geographic concentration | Others
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	34%	35%	35%	37%

Leases - Narrative (Details)

Leases - Narrative (Details)	Jul. 31, 2022 extension_option
Minimum
Lessee, Lease, Description [Line Items]
Number of lease extension options	1
Maximum
Lessee, Lease, Description [Line Items]
Operating renewal term (in years)	7 years

Leases - Components of Operatin

Leases - Components of Operating Leases and Operating Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Operating Leases
Operating lease right-of-use assets	$ 28,573		$ 28,573		$ 32,643
Operating lease liabilities, current portion	10,327		10,327		11,462
Operating lease liabilities, net of current portion	41,533		41,533		45,633
Total operating lease liabilities	51,860		51,860		$ 57,095
Lease Cost
Operating lease cost	2,618	$ 3,164	5,252	$ 6,380
Short-term operating lease costs	$ 109	$ 101	$ 199	$ 203

Leases - Future Maturities of O

Leases - Future Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Maturities of Operating Lease Liabilities
2023 (remainder of the year)	$ 7,467
2024	10,988
2025	6,386
2026	6,242
2027	6,429
Thereafter	23,468
Total lease payments	60,980
Less imputed interest	(9,120)
Present value of lease liabilities	$ 51,860	$ 57,095

Leases - Supplemental Informati

Leases - Supplemental Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Lease Term and Discount Rate
Weighted-average remaining operating lease term	6 years 9 months 18 days		6 years 9 months 18 days		7 years
Weighted-average operating lease discount rate (percent)	4.60%		4.60%		4.60%
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases	$ 3,408	$ 3,454	$ 6,822	$ 6,863
New right-of-use assets obtained in exchange for lease liabilities:
Operating leases obtained	$ 0	$ 0	$ 0	$ 3,923

Commitments and Contingencies (

Commitments and Contingencies (Details)	1 Months Ended				2 Months Ended
	Jul. 31, 2020 lawsuit	Jun. 30, 2020 lawsuit	Feb. 29, 2020 lawsuit	Sep. 30, 2019 lawsuit	Mar. 31, 2021 lawsuit	Jun. 30, 2020 lawsuit	May 31, 2020 lawsuit	Jul. 31, 2022 USD ($) vendor	Jan. 31, 2022 USD ($)
Cloud computing services
Other Commitments [Line Items]
Contractual obligation | $								$ 45,900,000
Number of vendors related to contractual obligation | vendor								1
Putative securities class action
Other Commitments [Line Items]
Number of lawsuits filed							2
Number of lawsuits consolidated	2
Stockholder derivative lawsuits, CA
Other Commitments [Line Items]
Number of lawsuits filed				2
Number of lawsuits consolidated			2
Stockholder derivative lawsuits, DE
Other Commitments [Line Items]
Number of lawsuits filed						2
Number of lawsuits consolidated		2
Stockholder derivative lawsuits, Delaware Chancery Court
Other Commitments [Line Items]
Number of lawsuits filed					2
Number of lawsuits consolidated					2
Irrevocable letters of credit | Certain facility lease agreements
Other Commitments [Line Items]
Letters of credit available | $								$ 4,500,000	$ 4,500,000
Letters of credit outstanding | $								$ 0	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Loss before income taxes	$ (29,381)	$ (23,455)	$ (52,241)	$ (40,743)
Income tax provision	$ 529	$ 238	$ 837	$ 611
Effective tax rate	(1.80%)	(1.00%)	(1.60%)	(1.50%)

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details)	Jul. 31, 2022 vote $ / shares shares
Class of Stock [Line Items]
Preferred stock authorized (in shares)	10,000,000
Preferred stock par value (in dollars per share) | $ / shares	$ 0.0001
Preferred stock issued (in shares)	0
Preferred stock outstanding (in shares)	0
Class A common stock
Class of Stock [Line Items]
Number of votes for each share of stock held (in votes) | vote	1
Common stock authorized (in shares)	500,000,000
Common stock par value (in dollars per share) | $ / shares	$ 0.0001
Common stock issued (in shares)	123,800,000
Common stock outstanding (in shares)	123,800,000
Class B common stock
Class of Stock [Line Items]
Number of votes for each share of stock held (in votes) | vote	10
Common stock authorized (in shares)	500,000,000
Common stock par value (in dollars per share) | $ / shares	$ 0.0001
Common stock issued (in shares)	8,100,000
Common stock outstanding (in shares)	8,100,000

Stockholders' Equity - Componen

Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Components of accumulated other comprehensive loss
Beginning balance	$ 188,856	$ 171,507	$ 170,607	$ 171,913
Foreign currency translation adjustment	(316)	(174)	(675)	(259)
Unrealized loss on available-for-sale securities	(278)	0	(676)	(34)
Ending balance	192,665	177,342	192,665	177,342
AOCI
Components of accumulated other comprehensive loss
Beginning balance	(865)	677	(108)	796
Ending balance	(1,459)	$ 503	(1,459)	$ 503
Foreign Currency Translation Adjustment
Components of accumulated other comprehensive loss
Beginning balance			118
Foreign currency translation adjustment			(675)
Ending balance	(557)		(557)
Unrealized Loss on Available-for-Sale Securities
Components of accumulated other comprehensive loss
Beginning balance			(226)
Unrealized loss on available-for-sale securities			(676)
Ending balance	$ (902)		$ (902)

Employee Stock Plans - Narrativ

Employee Stock Plans - Narrative (Details) shares in Millions	6 Months Ended
	Jul. 31, 2022 purchase_period shares
2018 Equity Incentive Plan | Class A common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved and available for issuance (in shares)	28.2
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP offering period (in months)	24 months
Number of purchase periods in offering period | purchase_period	4
Term of purchase period (in months)	6 months
Purchase price, percentage of fair market value	85%
2018 ESPP | Class A common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved and available for issuance (in shares)	4.6
Stock Options and RSUs | 2006 Stock Plan and 2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate equity awards outstanding (in shares)	4.4

Employee Stock Plans - Stock Op

Employee Stock Plans - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares
Shares Subject To Outstanding Stock Options
Outstanding, beginning balance (in shares) | shares	8,560
Granted (in shares) | shares	20
Exercised (in shares) | shares	(288)
Forfeited (in shares) | shares	(194)
Outstanding, ending balance (in shares) | shares	8,098	8,560
Exercisable (in shares) | shares	4,408
Vested and expected to vest (in shares) | shares	7,928
Weighted-Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share) | $ / shares	$ 9.22
Granted (in dollars per share) | $ / shares	12.52
Exercised (in dollars per share) | $ / shares	5.31
Forfeited (in dollars per share) | $ / shares	12.90
Weighted average exercise price, ending balance (in dollars per share) | $ / shares	9.28	$ 9.22
Exercisable (in dollars per share) | $ / shares	4.49
Vested and expected to vest (in dollars per share) | $ / shares	$ 9.18
Average Remaining Contractual Term (Years)
Average remaining contractual term (years), outstanding	5 years 4 months 24 days	5 years 10 months 24 days
Average remaining contractual term (years), exercisable	3 years 6 months
Average remaining contractual term (years), vested and expected to vest	5 years 3 months 18 days
Aggregate Intrinsic Value
Aggregate intrinsic value, outstanding | $	$ 17,704	$ 67,259
Aggregate intrinsic value, exercisable | $	17,704
Aggregate intrinsic value, vested and expected to vest | $	$ 17,704

Employee Stock Plans - Grant Da

Employee Stock Plans - Grant Date Fair Value and Intrinsic Value of Options Exercised (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-Based Payment Arrangement [Abstract]
Weighted average grant date fair value per share of options granted (in dollars per share)	$ 5.54	$ 6.54	$ 5.54	$ 6.54
Aggregate intrinsic value of options exercised during each respective period	$ 941	$ 8,147	$ 2,030	$ 14,738

Employee Stock Plans - Valuatio

Employee Stock Plans - Valuation Assumptions for Estimated Fair Value of Stock Options (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)			$ 12.52
Expected volatility (percent)			42.60%
Expected term (years)			5 years 9 months 18 days
Risk-free interest rate (percent)			3%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)	$ 12.52
Expected volatility (percent)	42.60%
Expected volatility, minimum (percent)		42.60%		42.30%
Expected volatility, maximum (percent)		42.70%		42.70%
Expected term (years)	5 years 9 months 18 days	6 years
Risk-free interest rate (percent)	3%
Risk-free interest rate, minimum (percent)		1%		1%
Risk-free interest rate, maximum (percent)		1.10%		1.10%
Expected dividend yield (percent)	0%	0%	0%	0%
Stock Options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)		$ 15.64		$ 15.64
Expected term (years)				6 years
Stock Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)		$ 15.87		$ 15.87
Expected term (years)				6 years 1 month 6 days

Employee Stock Plans - RSU and

Employee Stock Plans - RSU and PSU Activity (Details) shares in Thousands	6 Months Ended
	Jul. 31, 2022 $ / shares shares
RSUs
Number Outstanding
Outstanding, beginning balance (in shares) | shares	12,171
Granted (in shares) | shares	6,886
Vested (in shares) | shares	(2,895)
Forfeited (in shares) | shares	(1,571)
Outstanding, ending balance (in shares) | shares	14,591
Weighted-Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 15.46
Granted (in dollars per share) | $ / shares	12.84
Vested (in dollars per share) | $ / shares	15.25
Forfeited (in dollars per share) | $ / shares	14.24
Outstanding, ending balance (in dollars per share) | $ / shares	$ 14.40
PSUs
Number Outstanding
Outstanding, beginning balance (in shares) | shares	0
Granted (in shares) | shares	2,905
Vested (in shares) | shares	0
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,905
Weighted-Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	15.21
Vested (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	0
Outstanding, ending balance (in dollars per share) | $ / shares	$ 15.21

Employee Stock Plans - Valuat_2

Employee Stock Plans - Valuation Assumptions for Estimated Fair Value of ESPP (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)			$ 12.52
Expected term (in years)			5 years 9 months 18 days
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)	$ 8.91	$ 16.07	$ 8.91	$ 16.07
Expected volatility, minimum (percent)			44.40%	41.80%
Expected volatility, maximum (percent)			52.30%	53.20%
Risk-free interest rate, minimum (percent)			2.30%	0.10%
Risk-free interest rate, maximum (percent)			3.20%	0.20%
Expected dividend yield (percent)	0%	0%	0%	0%
2018 ESPP | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)			6 months	6 months
2018 ESPP | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)			2 years	2 years

Employee Stock Plans - Stock-Ba

Employee Stock Plans - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Cost of Revenue
Stock-based compensation expense	$ 28,213	$ 18,069	$ 51,038	$ 31,866
Cost of subscription revenue
Cost of Revenue
Stock-based compensation expense	2,281	1,534	4,080	2,577
Cost of professional services revenue
Cost of Revenue
Stock-based compensation expense	3,690	2,664	6,707	4,665
Research and development
Cost of Revenue
Stock-based compensation expense	7,465	5,243	13,431	9,772
Sales and marketing
Cost of Revenue
Stock-based compensation expense	9,959	5,615	17,415	9,695
General and administrative
Cost of Revenue
Stock-based compensation expense	$ 4,818	$ 3,013	$ 9,405	$ 5,157

Employee Stock Plans - Unrecogn

Employee Stock Plans - Unrecognized Compensation Cost (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, stock options	$ 7,963
Weighted-average recognition period (in years)	2 years 1 month 6 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 172,767
Weighted-average recognition period (in years)	2 years 4 months 24 days
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 12,341
Weighted-average recognition period (in years)	2 years 1 month 6 days
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 9,120
Weighted-average recognition period (in years)	1 year 3 months 18 days

Warrants to Purchase Shares o_3

Warrants to Purchase Shares of Common Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions		3 Months Ended		6 Months Ended
	Mar. 24, 2022	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Class of Warrant or Right [Line Items]
Warrant liability		$ 3,147		$ 3,147		$ 0
Gain on valuation of liability-classified warrants		$ (4,524)	$ 0	$ (8,896)	$ 0
Silver Lake Warrants
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)	7.5	7.5		7.5
Warrants term	7 years
Term after initial closing date for required written approval	18 months
Make-Whole Fundamental Change scenarios, issuance of stock as percentage of outstanding shares for requirement of shareholder approval	20%
Warrants classified as liability (in shares)	2.8
Warrant liability	$ 12,000
Gain on valuation of liability-classified warrants		$ (4,500)		$ 8,900
Silver Lake Warrants | Warrants, tranche one
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)	2.5
Exercise price of warrants (in dollars per share)	$ 20
Silver Lake Warrants | Warrants, tranche two
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)	2.5
Exercise price of warrants (in dollars per share)	$ 22
Silver Lake Warrants | Warrants, tranche three
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)	2.5
Exercise price of warrants (in dollars per share)	$ 24

Warrants to Purchase Shares o_4

Warrants to Purchase Shares of Common Stock - Valuation Inputs (Details) - Warrant liability	Apr. 30, 2022	Mar. 24, 2022	Jul. 31, 2022
Fair value of common stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.77	7.60
Restriction period (in months)	18 months	18 months
Exercise price (in dollars per share) | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		22	22
Exercise price (in dollars per share) | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		24	24
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.419	0.403
Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input, term		7 years	6 years 8 months 12 days
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.024	0.027
Expected dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0	0

Net Loss Per Share - Basic and

Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Numerator:
Net loss	$ (29,910)	$ (23,693)	$ (53,078)	$ (41,354)
Denominator:
Weighted-average common shares outstanding, basic (in shares)	130,280	123,134	129,384	122,259
Weighted-average common shares outstanding, diluted (in shares)	130,280	123,134	129,384	122,259
Net loss per share, basic (in dollars per share)	$ (0.23)	$ (0.19)	$ (0.41)	$ (0.34)
Net loss per share, diluted (in dollars per share)	$ (0.23)	$ (0.19)	$ (0.41)	$ (0.34)

Net Loss Per Share - Potentiall

Net Loss Per Share - Potentially Dilutive Securities Not Included in the Diluted Per Share Calculations (Details) - shares shares in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	45,802	23,131
Initial Notes conversion
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	12,500	0
Unvested RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	14,591	12,845
Issued and outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	8,098	10,142
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	7,500	0
Unvested PSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	2,905	0
Shares committed under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	208	144

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Zephr Inc $ in Millions	Aug. 23, 2022 USD ($)
Subsequent Event [Line Items]
Purchase price adjustments, net	$ 44
Payments to acquire additional interest in subsidiaries	$ 6